Actively Recruiting

Phase Not Applicable
Age: 18Years - 64Years
All Genders
NCT03348761

rTMS Response Trajectories in Depression

Led by Chinese University of Hong Kong · Updated on 2024-02-12

70

Participants Needed

1

Research Sites

591 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Notwithstanding the cumulative evidence on the safety and efficacy of transcranial magnetic stimulation in depression care, the non-response rate to transcranial magnetic stimulation (TMS) amongst treatment-resistant depression has remained substantial despite the health care cost and time incurred. There remains a compelling clinical need to find valid biomarkers to inform personalized treatment. Using supervised machine learning on 4 combined features of neuroimaging markers, our group recently reported excellent prediction for clinical response in 70 patients receiving TMS to left dorsolateral prefrontal cortex for medication-resistant major depression in 2015-18 (Phase 1 study).The clinical utility of these potential neuroimaging biomarkers is still uncertain without further validation of the trained model in an independent clinical cohort.

CONDITIONS

Official Title

rTMS Response Trajectories in Depression

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Right-handed
  • Diagnosis of major depressive disorder according to DSM-IV
  • Moderate or more severe episode with MADRS score >20 and HDRS 17-item score >18
  • Failed to respond to at least one full course (>6 weeks) of antidepressant medication or medication intolerant
Not Eligible

You will not qualify if you...

  • Significant head trauma
  • Active abuse of alcohol or illegal substances
  • Current psychotic symptoms
  • Suicide ideation or recent suicide attempts
  • Other DSM-IV Axis I and II psychiatric diagnoses
  • Neurological disorders
  • Contraindications to fMRI (e.g., pacemakers, metal implants, pregnancy) or rTMS
  • Electroconvulsive therapy within the past year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Psychiatry, CUHK

Hong Kong, Hong Kong, 852

Actively Recruiting

Loading map...

Research Team

T

The Department of Psychiatry

CONTACT

H

Helene J Hopman

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here